Lataa...
Clinical Challenges to Current Molecularly Targeted Therapies in Lung Cancer
Lung cancer is difficult to treat with a poor prognosis and a five year survival of 15%. Current molecularly targeted therapies are initially effective in non-small cell lung cancer (NSCLC) patients; however, they are plagued with difficulties including induced resistance and small therapeutically r...
Tallennettuna:
| Julkaisussa: | Arch Cancer Res |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4894332/ https://ncbi.nlm.nih.gov/pubmed/27280107 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|